KRISTEN TURNER: Open Payments
NPI 1306565155 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 14 payments from 7 companies in 2025. Trend: 2023 $763 · 2024 $373 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $61 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, Auvelity, INVEGA SUSTENNA, FANAPT, REXULTI, COBENFY.
Industry payments across KY — which companies pay providers there.
